FDA.reportPublic FDA data

SARS-CoV-2 total antibody IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of total antibodies to severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, in a clinical specimen.
GUDID devices
9
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00630414605425DV/DM COV2T/CV2T POS/NEG CTRLSiemens Healthcare Diagnostics Inc.114174152021-08-09
10758750035465VITROSORTHO CLINICAL DIAGNOSTICS61744422023-11-22
20758750035462VITROSORTHO CLINICAL DIAGNOSTICS61744422023-11-22
05055273216936SARS CoV-2 Controls (SARS-CoV-2)RANDOX LABORATORIES LIMITEDCOV104602022-09-22
00630414297620DV/DM COV2T/CV2T POS/NEG CTRLSiemens Healthcare Diagnostics Inc.114174152021-08-09
B085K921M50Audit MicroControls Linearity LQ Anti-SARS-CoV-2 S for Roche SystemsAALTO SCIENTIFICK921M-52021-06-07
10758750033409VITROSORTHO CLINICAL DIAGNOSTICS61999242021-03-22
00816784020970ACCURUN® Anti-SARS-CoV-2 Controls Kit Series 2000Lgc Clinical Diagnostics, Inc.2015-02252020-12-03
08809317540917COVID-19 total Ab Control LQNanoEnTek, Inc.FIC-COALQ2020-09-02